Tdam USA Inc. raised its stake in Clorox Company (The) (NYSE:CLX) by 3.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,075 shares of the company’s stock after buying an additional 330 shares during the period. Tdam USA Inc.’s holdings in Clorox Company (The) were worth $1,476,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CLX. BlackRock Inc. boosted its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the period. Parnassus Investments CA bought a new stake in shares of Clorox Company (The) during the first quarter valued at about $434,255,000. Vanguard Group Inc. boosted its stake in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares during the period. Morgan Stanley boosted its stake in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock valued at $134,342,000 after buying an additional 241,210 shares during the period. Finally, WINTON GROUP Ltd boosted its stake in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock valued at $28,566,000 after buying an additional 201,737 shares during the period. Hedge funds and other institutional investors own 69.83% of the company’s stock.

Clorox Company (NYSE:CLX) opened at 135.57 on Tuesday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The firm’s 50 day moving average price is $133.48 and its 200-day moving average price is $133.84. The stock has a market cap of $17.50 billion, a price-to-earnings ratio of 25.41 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the company earned $1.30 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. On average, equities analysts anticipate that Clorox Company will post $5.67 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Stake Boosted by Tdam USA Inc.” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.watchlistnews.com/clorox-company-the-clx-stake-boosted-by-tdam-usa-inc/1488982.html.

Several analysts have issued reports on the company. UBS AG reaffirmed a “sell” rating and set a $121.00 target price (up previously from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. Jefferies Group LLC reaffirmed a “hold” rating and set a $137.00 target price (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the company a “hold” rating in a research report on Monday, April 24th. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price on the stock. in a research report on Tuesday, April 18th. Finally, BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. Clorox Company (The) has an average rating of “Hold” and an average price target of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.